Skip to content

13F-HR filed by First Light Asset Management, LLC

First Light Asset Management, LLC filed this 13F-HR for the quarter ended 2015-12-31, filed 2016-02-12, with 65 holding rows worth $238,755,000.

Accession
0001387131-16-004217
Filed
2016-02-12
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2015

A holdings report, 65 entries on the cover page, a total value of $238,755,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $238,755,000 with VALUE read as thousands by filing date, 13F file number 028-16064. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
NEOGENOMICS INC64049M209COM NEW3,089,881$24,317,000thousands by filing date
ATRICURE INC04963C209COM922,557$20,702,000thousands by filing date
AKORN INC009728106COM341,453$12,740,000thousands by filing date
Enzo Biochem Inc294100102Common Stock2,288,292$10,297,000thousands by filing date
TELIGENT INC NEW87960W104COM998,610$8,888,000thousands by filing date
LHC GROUP50187A107COM162,188$7,345,000thousands by filing date
HARVARD BIOSCIENCE INC416906105COM2,039,753$7,078,000thousands by filing date
ENDOLOGIX INC29266S106COM702,824$6,958,000thousands by filing date
ENTELLUS MED INC29363K105COM391,497$6,601,000thousands by filing date
LEMAITRE VASCULAR INC525558201COM381,849$6,587,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW56,818$6,160,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS500,697$5,758,000thousands by filing date
AMEDISYS INC023436108COM146,287$5,752,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK251,093$5,501,000thousands by filing date
PHYSICIANS REALTY TRUST71943U104COM317,817$5,358,000thousands by filing date
TEARLAB CORP878193101COM3,761,436$5,228,000thousands by filing date
ALKERMES PLCG01767105SHS63,484$5,039,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock252,495$4,583,000thousands by filing date
CYNAPSUS THERAPEUTICS INC23257Y859COM PAR NO PAR296,072$4,527,000thousands by filing date
LDR HLDG CORP50185U105COM177,065$4,446,000thousands by filing date
BLUEBIRD BIO INC09609G100COM66,104$4,245,000thousands by filing date
QUIDEL CORP74838J101COM195,243$4,139,000thousands by filing date
MEDIVATION INC58501N101COM83,816$4,052,000thousands by filing date
SPECTRANETICS CORP84760C107COM265,762$4,002,000thousands by filing date
RTI BIOLOGICS INC74975N105COM1,005,889$3,993,000thousands by filing date
VERACYTE INC COM92337F107Stock532,574$3,835,000thousands by filing date
MEDICINES CO584688105COM93,656$3,497,000thousands by filing date
ENVISION HEALTHCARE HLDGS IN29413U103COM133,187$3,459,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM208,343$3,267,000thousands by filing date
ANGIODYNAMICS INC03475V101COM262,089$3,182,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM24,320$3,060,000thousands by filing date
ARROWHEAD RESEARCH CORP042797209COM463,140$2,848,000thousands by filing date
IMMUNOMEDICS INC452907108COM850,757$2,612,000thousands by filing date
HEALTHSTREAM INC42222N103COM117,006$2,574,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM1,739,045$2,452,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock530,391$2,238,000thousands by filing date
BIO-TECHNE CORP09073M104COM24,556$2,210,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM395,043$2,204,000thousands by filing date
CEPHEID15670R107COM59,691$2,181,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM152,765$2,024,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM18,901$1,980,000thousands by filing date
ALLERGAN PLCG0177J108SHS2,035$636,000thousands by filing date
HUMANA INC COM444859102Stock3,540$632,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock3,820$598,000thousands by filing date
Elevance Health, Inc.036752103COM4,095$571,000thousands by filing date
Bristol-Myers Squibb Company110122108COM8,290$570,000thousands by filing date
AETNA INC NEW00817Y108COM5,215$564,000thousands by filing date
MYLAN NVN59465109SHS EURO9,775$529,000thousands by filing date
BECTON DICKINSON & CO075887109COM3,395$523,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR6,070$522,000thousands by filing date
CELGENE CORP151020104COM4,280$513,000thousands by filing date
ENDO INTL PLCG30401106SHS8,161$500,000thousands by filing date
BIOSCRIP INC09069N108COM281,546$493,000thousands by filing date
STERIS CORP859152100COMMON STOCK6,330$477,000thousands by filing date
Eli Lilly and Company532457108COM5,495$463,000thousands by filing date
Johnson & Johnson478160104COM3,820$392,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR11,360$386,000thousands by filing date
Amgen Inc.031162100COM2,330$378,000thousands by filing date
ST JUDE MED INC790849103COM6,055$374,000thousands by filing date
Merck & Co.,Inc.58933Y105COM6,610$349,000thousands by filing date
Pfizer Inc.717081103COM10,520$340,000thousands by filing date
MYRIAD GENETICS INC62855J104COM7,820$338,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR5,680$242,000thousands by filing date
BIO RAD LABS INC090572207CL A1,675$232,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock5,120$214,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001387131-16-004217this filing2016-02-12acceptance time not in the bulk data set